Alumis (ALMS) Free Cash Flow (2023 - 2025)
Alumis' (ALMS) quarterly Free Cash Flow came in at -$76.8 million in Q4 2025, down 2.18% year-on-year from -$78.5 million in Q4 2024, and up 30.79% on a QoQ basis from -$110.9 million in Q3 2025.
Alumis (ALMS) Free Cash Flow (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Free Cash Flow data on file, last reported at -$76.8 million in Q4 2025.
- On a quarterly basis, Free Cash Flow fell 2.18% year-over-year to -$76.8 million in Q4 2025; TTM through Dec 2025 was -$375.0 million, a 46.04% decrease from a year earlier, with the FY2025 full-year figure at -$375.0 million, down 46.04% from the prior year.
- Free Cash Flow for Q4 2025 stood at -$76.8 million, up from -$110.9 million in the prior quarter.
- Over the last five years, Free Cash Flow for ALMS reached as high as -$35.0 million in Q4 2023 and fell as low as -$110.9 million in Q3 2025.
- Historically, Free Cash Flow has averaged -$70.2 million across 3 years, with a median of -$75.9 million in 2024.
- Across the five-year window, Free Cash Flow slumped 139.05% in 2024 and fell 2.18% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$35.0 million in 2023, then plunged by 114.6% to -$75.1 million in 2024, then slipped by 2.18% to -$76.8 million in 2025.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$76.8 million in Q4 2025, -$110.9 million in Q3 2025, and -$106.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | -76.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -76.77 Mn |
| Dec 31, 2025 | -76.77 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Sep 30, 2025 | -110.92 Mn |
| Jun 30, 2025 | -106.92 Mn |
| Jun 30, 2025 | -106.92 Mn |
| Mar 31, 2025 | -80.44 Mn |
| Mar 31, 2025 | -80.44 Mn |
| Dec 31, 2024 | -75.13 Mn |
| Dec 31, 2024 | -75.13 Mn |
| Sep 30, 2024 | -84.55 Mn |
| Sep 30, 2024 | -84.55 Mn |
| Jun 30, 2024 | -52.68 Mn |
| Jun 30, 2024 | -52.68 Mn |
| Mar 31, 2024 | -44.46 Mn |
| Mar 31, 2024 | -44.46 Mn |
| Dec 31, 2023 | -35.01 Mn |
| Dec 31, 2023 | -35.01 Mn |
| Sep 30, 2023 | -35.37 Mn |
| Sep 30, 2023 | -35.37 Mn |